Summary of Purpose
This study is designed to evaluate the safety and efficacy of oral glibenclamide in acute ischemic stroke patients who under intravenous rt-PA thrombolysis.Read More →
The following dates are available for this trial. Trial information last updated on 25 April 2018.
|1 Jan 2018||14 Sep 2017||30 Sep 2020||30 Sep 2021||1 Apr 2018||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- Kaibin Huang, M.D., Ph.D.